Journal article
Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
- Abstract:
-
OBJECTIVE: An analysis of administrative and claims data was performed to compare the resource use and costs to a managed-care organisation of venlafaxine, a serotonin and norepinephrine reuptake inhibitor (SNRI), versus tricyclic antidepressant (TCA) therapy, after switching from a selective serotonin reuptake inhibitor (SSRI). DESIGN: One-year costs and frequencies of all medical services, and of services coded for depression, were compared between patients who received venlafaxine and TCA ...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- PharmacoEconomics
- Volume:
- 15
- Issue:
- 5
- Pages:
- 495-505
- Publication date:
- 1999-05-01
- DOI:
- EISSN:
-
1179-2027
- ISSN:
-
1170-7690
- Source identifiers:
-
359125
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:359125
- UUID:
-
uuid:ab791fa5-1fa1-4db4-a54b-2717bbb272b7
- Local pid:
- pubs:359125
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 1999
If you are the owner of this record, you can report an update to it here: Report update to this record